Check back here for frequent updates from Neuright as the product is developed through peer-validated science and technology, undergoes pre-clinical and clinical testing, and therapies and treatments are developed to treat peripheral neuropathy in all its forms.
Neuright, Inc., Earns National Science Foundation Small Business Technology Transfer Program Award
Rosemary Smith, Magdalena Blaszkiewicz and Kristy Townsend of the University of Maine founded Neuright, Inc.
Neuright, Inc., a University of Maine biotech spinout focused on the early diagnosis and treatment of peripheral neuropathy, has been awarded $225,000 under the National Science Foundation’s Small Business Technology Transfer (STTR) program to further develop its technology for delivery to market. Peripheral neuropathy is a condition in which nerve fibers die back from the skin, and is estimated to affect more than 20 million people in the U.S. with symptoms including pain, numbness and loss of limb control. Diabetes, which affects an estimated 34 million Americans, is the leading cause of peripheral neuropathy—up to 70 percent of those with diabetes also have peripheral neuropathy. Wide-ranging and variable symptoms make peripheral neuropathy difficult to diagnose, and while there is no cure, early intervention and treatment can help patients minimize and manage the often debilitating effects. Recognizing an opportunity to address these issues, Magdalena Blaszkiewicz, who graduated from UMaine in 2019 with a doctoral degree in biomedical sciences, and Kristy Townsend, an associate professor of neurobiology, co-founded Neuright in 2018 to create and commercialize an affordable medical device to measure nerve conduction and stimulate the regrowth of nerves. The company’s founders took advantage of several new and existing programs that help advance university research toward commercialization and are offered by or connected with UMaine’s Office of Innovation and Economic Development. Read more here.
Mainebiz Features Neuright, Inc., Award from National Science Foundation Small Business Technology Transfer Program An article in Mainebiz, a website covering business news in Maine, featured Neuright Inc., a University of Maine biotech spinoff focused on the early diagnosis and treatment of peripheral neuropathy. The reason for the story was that Neuright was awarded $225,000 under the National Science Foundation’s Small Business Technology Transfer program to develop its technology for delivery to market. Read the entire article here.
Neuright, Inc., Founders to Speak at Maine Life Sciences Venture Summit
Join the Maine Center for Entrepreneurs 2020 Life Sciences Venture Summit for the secondof three sessions to learn how Maine’s entrepreneurial ecosystem supports Maine startups that have created innovative clinical solutions, and what additional steps we need to take to foster and grow more life sciences companies like them. Magdalena Blaszkiewicz and Kristy Townsend of Neuright, Inc., will be participating.The session will be highly interactive so you will be able to participate and ask questions.For more information or to register, click here.
Black Point Group Notes the Biotech and Bioscience Industry Is Strong in Maine Entrepreneurial tech businesses have emerged to become a powerful force in Maine’s economy over the past several decades. Learn more in this video webinar from the Black Point Group.
Neuright Cofounder Dr. Kristy Townsend Shares Her Entrepreneurial Story
On September 27, 2019, Neuright cofounder Dr. Kristy Townsend will appear on a panel entitled Empowering Women in Innovation & Entrepreneurship at the University of Maine. Dr. Townsend and two other accomplished panelists will share their stories about what it takes to be truly innovative and entrepreneurial, while overcoming systemic challenges in the workplace. To learn how to attend the event or for more information, please follow this link.
Neuright Wins $25,000 Prize in Maine Entrepreneur Event Neuright won one of two top prizes in the Top Gun Showcase, a tournament-style event where participants pitch their business idea for a shot at winning cash prizes. Neuright CEO Magdalena Blaszkiewicz, a UMaine doctoral candidate, made the case for the company’s development of a “theragnostic platform” that will provide reliable, early diagnosis of peripheral neuropathy and deliver therapeutic and drug treatments. As a result, Neuright won one of two $25,000 awards for their pitch. Top Gun is a three-month entrepreneurial training program developed by the Maine Center for Entrepreneurs (MCE). More than 40 entrepreneurs went through the program in 2019. The Showcase event featured two finalists from each of the regional pitch-off events held in Portland, Bangor, Lewiston/Auburn, Waterville, and Rockland. Two $25,000 cash prizes were up for grabs, one provided by the Maine Technology Institute and the other by the David Evans Shaw Family Foundation. Past winners include MyBodyModel, Thrivant Health in 2017, Revolution Research in 2016, and Rapport in 2015. See Neuright’s winning pitch here. https://youtu.be/gosjrUtvAYg
Neuright Participates in Maine Entrepreneur Pitch-Off Neuright participated in the Top Gun Entrepreneurship Accelerator Pitch-Off at the Top Gun Entrepreneurship Accelerator pitch-off in Bangor. Nine startup companies made five-minute pitches to judges in an attempt to secure a spot in the next round, where two winners will be awarded $25,000 prizes.